**POTENTIAL PANDEMIC SOLUTION** As governments and medical teams struggle with personal, medical and economic hardships caused by COVID-19, IBL is eager to promote our partnership with Medi-Immune, Ltd., of London. Medi-Immune has developed an immediate, patented solution to contain the spread of COVID-19, with additional patents for “Low Dose Immunity” technology that will offer immunity to any airborne pathogen.
For those with an interest to learn more, or a potential to help bring this technology to the open market and healthcare professionals that so urgently need it, please connect with Bill Bambara at BBambara@intl-businesslinks.com.